CAMP4 Therapeutics Corpor... (CAMP)
NASDAQ: CAMP
· Real-Time Price · USD
1.55
-0.03 (-1.90%)
At close: Jun 13, 2025, 3:59 PM
1.54
-0.65%
After-hours: Jun 13, 2025, 04:04 PM EDT
CAMP4 Therapeutics Revenue Breakdown
| Period Ending | Feb 28, 2023 | Feb 28, 2022 | Feb 28, 2021 | Feb 28, 2019 |
|---|---|---|---|---|
| Application Subscriptions And Other Services Revenue | 106.07M | 112.92M | 115.1M | 285.88M |
| Application Subscriptions And Other Services Revenue Growth | -6.07% | -1.89% | -59.74% | n/a |
| Product Revenue | 188.88M | 182.92M | 193.49M | n/a |
| Product Revenue Growth | +3.26% | -5.46% | n/a | n/a |
Revenue by Geography
| Period Ending | Feb 28, 2023 | Feb 28, 2022 | Feb 28, 2021 | Feb 29, 2020 | Feb 28, 2019 | Feb 28, 2018 |
|---|---|---|---|---|---|---|
| All Other Revenue | 4.33M | 3.1M | 10.06M | 14.11M | 6.94M | 5.94M |
| All Other Revenue Growth | +39.46% | -69.17% | -28.69% | +103.17% | +16.92% | n/a |
| Asia Pacific Revenue | 18.45M | 19.03M | 12.28M | 9.17M | 13.96M | 12.87M |
| Asia Pacific Revenue Growth | -3.04% | +54.94% | +33.98% | -34.33% | +8.43% | n/a |
| Emea Revenue | 54.7M | 197.18M | 200.66M | 266.41M | 268.45M | 265.61M |
| Emea Revenue Growth | -72.26% | -1.74% | -24.68% | -0.76% | +1.07% | n/a |
| Latin America Revenue | 32.01M | n/a | n/a | n/a | n/a | n/a |
| Latin America Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 185.47M | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 | Feb 29, 2020 | Nov 30, 2019 | Aug 31, 2019 | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 | Aug 31, 2018 | May 31, 2018 | Feb 28, 2018 | Nov 30, 2017 | Aug 31, 2017 | May 31, 2017 | Feb 28, 2017 | Nov 30, 2016 | Aug 31, 2016 | May 31, 2016 | Feb 29, 2016 | Nov 30, 2015 | Aug 31, 2015 | May 31, 2015 | Feb 28, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.81M | 4.69M | 3.81M | 3.27M | 3.13M | 19M | 19.63M | 22.38M | 22.65M | 23.66M | 26.26M | 26.64M | 24.49M | 26.01M | 25.25M | 25.15M | 25.63M | 28.29M | 27.39M | 26.55M | 28.34M | 28.97M | 28.76M | 32.13M | 6.05M | 24.46M | 24.51M | 25.93M | 25.86M | 23.97M | 23.27M | 29.08M | 29.52M | 24.17M | 23.97M | 27.29M | 16.24M | 11.18M | 10.76M | 10.27M | 9.23M |
| Selling, General, and Administrative Revenue Growth | -18.72% | +22.97% | +16.53% | +4.40% | -83.50% | -3.23% | -12.27% | -1.19% | -4.28% | -9.92% | -1.41% | +8.78% | -5.86% | +3.05% | +0.39% | -1.89% | -9.39% | +3.27% | +3.15% | -6.32% | -2.14% | +0.71% | -10.49% | +431.09% | -75.27% | -0.20% | -5.47% | +0.29% | +7.86% | +3.02% | -19.98% | -1.48% | +22.12% | +0.85% | -12.18% | +68.05% | +45.30% | +3.92% | +4.69% | +11.29% | n/a |
| Research and Development Revenue | 10.15M | 10M | 9.7M | 9.56M | 9.74M | 4.05M | 4.8M | 5.84M | 5.33M | 5.48M | 6.76M | 7M | 6.6M | 7.18M | 7.73M | 6.94M | 6.89M | 6.78M | 6.99M | 6.32M | 6.88M | 7.74M | 7.92M | 6.89M | 6.28M | 7.18M | 7.6M | 6.6M | 6.91M | 6.3M | 6.72M | 5.83M | 4.73M | 5.3M | 5.88M | 6.09M | 5.12M | 5.12M | 5M | 4.57M | 4.87M |
| Research and Development Revenue Growth | +1.50% | +3.03% | +1.44% | -1.80% | +140.43% | -15.60% | -17.84% | +9.52% | -2.65% | -18.91% | -3.47% | +6.12% | -8.12% | -7.12% | +11.37% | +0.78% | +1.52% | -2.95% | +10.52% | -8.13% | -11.08% | -2.30% | +15.07% | +9.67% | -12.51% | -5.55% | +15.12% | -4.44% | +9.72% | -6.38% | +15.31% | +23.25% | -10.67% | -9.99% | -3.38% | +18.92% | +0.02% | +2.52% | +9.42% | -6.22% | n/a |